RecruitingNCT06527157
Investigations of Reproductive Cancers in Women
PROspective ACcrual To Investigate reprOductive Cancers in womeN
Sponsor
PinkDx, Inc.
Enrollment
4,500 participants
Start Date
Jul 30, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to create a non-invasive diagnostic test to rule out gynecological cancer in females aged 45 and older with abnormal uterine or postmenopausal bleeding.
Eligibility
Sex: FEMALEMin Age: 45 YearsMax Age: 100 Years
Plain Language Summary
Simplified for easier understanding
This study is testing a new diagnostic tool to detect endometrial (uterine) cancer or other causes of abnormal uterine bleeding in women who are being worked up for this symptom. The device collects samples non-invasively, and researchers hope it can detect cancer markers early — potentially offering a less invasive alternative to current diagnostic procedures.
**You may be eligible if...**
- You are a woman aged 45 or older (most participants will be over 50)
- You still have a uterus
- You are currently being evaluated for abnormal uterine bleeding (AUB) or post-menopausal bleeding (PMB)
- You are able to complete study visits and be contacted by phone during the study
**You may NOT be eligible if...**
- You have had a hysterectomy (uterus removed)
- You have a known history of endometrial cancer or uterine sarcoma
- You have previously been treated for endometrial cancer
- You are suspected to be pregnant
- You have used a tampon within 7 days of sample collection
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06527157
Related Trials
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
NCT057586883 locations
[18F]FES PET/.CT in Uterine Cancer
NCT059161961 location
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT0557936666 locations
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
NCT060241092 locations
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
NCT057435171 location